Chronic renal insufficiency in heart transplant recipients: risk factors and management options.

Item

http://www.wikidata.org/entity/Q38240994

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Chronic renal insufficiency in ...... actors and management options.

@en

type

Item

label

Chronic renal insufficiency in ...... actors and management options.

@en

prefLabel

Chronic renal insufficiency in ...... actors and management options.

@en

P1476

Chronic renal insufficiency in ...... actors and management options.

@en

P2093

Francisco González-Vílchez

http://www.w3.org/2001/XMLSchema#string

José Antonio Vázquez de Prada

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic renal failure after transplantation of a nonrenal organ

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial.

Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial.

Renal disease in recipients of nonrenal solid organ transplantation.

Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study.

Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.

P2888

s40265-014-0274-9

P304

1481-1494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-014-0274-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025077397

http://www.w3.org/2001/XMLSchema#string

P698

25134671

http://www.w3.org/2001/XMLSchema#string